NCT02531607

Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)

RecruitingOBSERVATIONAL

Trial Details

Start: 2014-11-13Est. Completion: 2026-12-01

Enrollment target: 500 participants

Locations

AdventHealth, Orlando, Florida, United States

Other microbiome trials you might be interested in

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine TumoursPhase 2Recruiting

Neuroendocrine Tumors

Neuroendocrine tumours (NETs) are slow growing cancers, which commonly present as metastatic incurable disease. Some neu…

Sydney, AustraliaEst. completion Sep 2027

View Trial →

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerPhase 1Recruiting

Metastatic Lung Small Cell CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Neuroendocrine CarcinomaMetastatic Pancreatic AdenocarcinomaStage III Lung Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.